Literature DB >> 21526280

[Bacteriological quality of air in a ward for sterile pharmaceutical preparations].

Beatriz Caorsi P1, Andrea Sakurada Z, M Teresa Ulloa F, Marcela Pezzani V, Paz Latorre O.   

Abstract

BACKGROUND: An extremely clean area is required for preparation of sterile pharmaceutical compounds, in compliance with international standards, to minimize the probability of microbial contamination. AIM: To evaluate the bacteriological quality of the air in the Sterile Pharmaceutical Preparation Unit of the University of Chile's Clinical Hospital and to set up alerts and action levels of bacterial growth.
METHODS: We studied eight representative sites of our Unit on a daily basis from January to February 2005 and twice a week from June 2005 to February 2006. We collected 839 samples of air by impact in the Petri dish.
RESULTS: 474 (56.5%) samples were positive; 17 (3.5%) of them had an inappropriate bacterial growth (2% of total samples). The samples from sites 1 and 2 (big and small biosafety cabinets) were negative. The countertop and transfer area occasionally exceeded the bacterial growth limits. The most frequently isolated bacteria were coagulase-negative staphylococci, Micrococcus spp and Corynebacterium spp, from skin microbiota, and Bacillus spp, an environmental bacteria.
CONCLUSIONS: From a microbiological perspective, the air quality in our sterile preparation unit complied with international standards. Setting institutional alerts and action levels and appropriately identifying bacteria in sensitive areas permits quantification of the microbial load and application of preventive measures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21526280     DOI: /S0716-10182011000100003

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  1 in total

1.  Effectiveness of anti-epidemic measures on ensuring indoor air quality of cleanrooms in a tertiary care hospital.

Authors:  Lukáš Fedor; Marie Nakládalová; Ladislav Štěpánek; Ondřej Holý; Ivanka Matoušková
Journal:  Cent Eur J Public Health       Date:  2022-06       Impact factor: 1.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.